Syed A. Hussain, MD, on Neoadjuvant Treatment With Nintedanib for Locally Advanced Disease

Posted: Friday, October 30, 2020

Syed A. Hussain, MD, of the University of Sheffield, discusses the efficacy of nintedanib as a neoadjuvant treatment, its toxicity, whether it differs from standard therapy, and how it affects surgical outcomes.